Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2020

Nov 24, 2020

30826_dirs_2020-11-23_c1f3c1ae-0bc6-484e-8b0f-36c856d80c98.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2020-11-19

Reporting Person: Hunt Anthony (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-19 Common Stock M 20000 $26.05 Acquired 253327 Direct
2020-11-19 Common Stock S 5447 $184.69 Disposed 247880 Direct
2020-11-19 Common Stock S 6823 $185.67 Disposed 241057 Direct
2020-11-19 Common Stock S 6300 $186.50 Disposed 234757 Direct
2020-11-19 Common Stock S 1430 $187.60 Disposed 233327 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-19 Stock Option (Right to Buy) $26.05 M 20000 Disposed 2026-02-26 Common Stock (20000) Direct

Footnotes

F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 11, 2020.

F2: $184.69 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.11 to $185.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: $185.67 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.12 to $186.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: $186.50 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.12 to $187.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: $187.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.19 to $189.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6: This option is currently exercisable.